<code id='96F8CFC4F9'></code><style id='96F8CFC4F9'></style>
    • <acronym id='96F8CFC4F9'></acronym>
      <center id='96F8CFC4F9'><center id='96F8CFC4F9'><tfoot id='96F8CFC4F9'></tfoot></center><abbr id='96F8CFC4F9'><dir id='96F8CFC4F9'><tfoot id='96F8CFC4F9'></tfoot><noframes id='96F8CFC4F9'>

    • <optgroup id='96F8CFC4F9'><strike id='96F8CFC4F9'><sup id='96F8CFC4F9'></sup></strike><code id='96F8CFC4F9'></code></optgroup>
        1. <b id='96F8CFC4F9'><label id='96F8CFC4F9'><select id='96F8CFC4F9'><dt id='96F8CFC4F9'><span id='96F8CFC4F9'></span></dt></select></label></b><u id='96F8CFC4F9'></u>
          <i id='96F8CFC4F9'><strike id='96F8CFC4F9'><tt id='96F8CFC4F9'><pre id='96F8CFC4F9'></pre></tt></strike></i>

          Home / entertainment / hotspot

          hotspot


          hotspot

          author:comprehensive    Page View:2
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In